癌症相关变异丰富CAVE是一种基因不可知的方法,用于识别慢性淋巴细胞白血病的低负担变异
Adar Yaacov1,2, Gregory Lazarian3,4, Tatjana Pandzic5,6
1Gaffin Center for Neuro-Oncology, Sharett Institute for Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Scientific reports
|September 20, 2024
概括
我们开发了CAVE,这是一种在测序数据中找到低负担癌症变体的工具. 这有助于识别真正的遗传驱动因素,改善癌症诊断和治疗决策.
科学领域:
- 基因组学就是基因组学.
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 内异质性构成临床挑战,因为具有特定遗传变化的低负荷克隆可以驱动治疗耐药性.
- 准确识别低负担癌症变异对于治疗决策至关重要,特别是对于慢性淋巴细胞白血病 (CLL) 中的TP53等基因.
- 在下一代测序 (NGS) 数据中,区分真正的低变异基因频率 (VAF) 突变与背景噪声对于可靠的临床测试至关重要.
研究的目的:
- 引入CAVE (癌症相关变异丰富),一种新型的基因不可知计算工具,旨在识别NGS数据中低负荷癌症驱动变异的丰富.
- 评估CAVE在检测CLL中低负荷TP53变异方面的表现,这是治疗决策中的关键步骤.
- 建立一种方法来区分临床上显著的低VAF变异与癌症测序中的技术噪声.
主要方法:
- 开发CAVE,这是一种用于识别NGS数据中的丰富低负荷变体的计算工具,能够检测低至0.3%的VAF的变体.
- 在CLL样本中将CAVE应用于TP53,以评估其在临床相关的癌症模型中的有用性.
- 在分析 (TP53依赖和独立) 确认已识别的变体的驾驶员状态.
- 使用数字滴状PCR (ddPCR) 和后续NGS分析进行变异识别的正交验证.
主要成果:
- 在CLL样本中,CAVE成功地确定了低负荷TP53变体的特定丰富,证明了其在非常低的VAF中检测变体的能力.
- 在分析证实了由CAVE检测到的变体的驱动性.
- 坐标验证方法,包括ddPCR和后续NGS,证实了CAVE的变体调用.
- 该工具在区分真正的低负荷变体与背景噪声方面被证明是有效的.
结论:
- CAVE是一种有效的基因不可知计算工具,用于在NGS数据中识别和丰富低负荷癌症驱动变体.
- 该工具对于提高变异调用准确度非常有价值,特别是对于临床决策中关键的低VAF突变,如CLL中的TP53.
- CAVE可以很容易地集成到现有的癌症NGS工作流程中,以加强对临床上显著的低负荷变体的检测.
更多相关视频
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.0K
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.0K
相关概念视频
01:33Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
02:30Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:18Lymphoid Cells and Tissues
1.0K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.0K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
03:18Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K